← Leaderboards
Sadanand Gite
Ambergen, Inc
$9,867,167
Attributed
$15,308,222
Total exposure
13
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$15,308,222 · 13
By mechanism
R44$9,214,796 · 5
R01$4,203,175 · 1
R43$1,890,251 · 7
Top collaborators
- Don Straus13 shared
Others in their field
Top investigators on “Cost”
- Eric S Lander · Whitehead Institute For Biomedical Res$748,368,930
- Richard K. Wilson · Washington University$429,230,873
- Richard A Gibbs · Baylor College Of Medicine$414,258,216
- David R. Weir · University Of Michigan At Ann Arbor$393,741,481
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
Research focus
CostMedicalSamplingDigital ImagingPerformanceTechnology /Technique DevelopmentBaseReagentTechnologyPathogenHourDesignCessation Of LifeDiagnostic TestsAntibioticsHospitalsLifePrototypeUser-FriendlyAwarenessDetectionDiagnosticInfectionCell Count
Grant awards (26)
Rapid detection of pathogens and antimicrobial susceptibility directly in patient samples$885,378
R01 · FY2018 · AI · contact PI
Rapid detection of pathogens and antimicrobial susceptibility directly in patient samples$879,278
R01 · FY2017 · AI · contact PI
Rapid detection of pathogens and antimicrobial susceptibility directly in patient samples$910,291
R01 · FY2016 · AI · contact PI
Rapid detection of pathogens and antimicrobial susceptibility directly in patient samples$1,528,228
R01 · FY2015 · AI · contact PI
Rapid sensitive low-cost test for resistant microbes causing hospital infections$942,482
R44 · FY2013 · AI · contact PI
Rapid sensitive low-cost test for resistant microbes causing hospital infections$981,430
R44 · FY2012 · AI · contact PI
Rapid, accurate and user-friendly clinical surge-testing for biothreat agents$997,518
R44 · FY2011 · AI · contact PI
Rapid sensitive low-cost test for resistant microbes causing hospital infections$982,928
R44 · FY2011 · AI · contact PI
Rapid, accurate and user-friendly clinical surge-testing for biothreat agents$997,518
R44 · FY2010 · AI · contact PI
Rapid, accurate and user-friendly clinical surge-testing for biothreat agents$997,518
R44 · FY2009 · AI · contact PI
Rapid sensitive low cost test for resistant microbes causing hospital infections$284,971
R43 · FY2009 · AI · contact PI
Rapid sensitive low cost test for resistant microbes causing hospital infections$284,971
R43 · FY2008 · AI · contact PI
Ultrasensitive, rapid, cost-effective, user-friendly test for respiratory viruses$209,600
R43 · FY2008 · AI · contact PI
Mass Spectrometric Detection of Drug-Resistant HIV$299,927
R43 · FY2005 · AI
Advanced Molecular Diagnostic Test for Neurofibromatosis$150,000
R43 · FY2005 · NS
Cell-Free Protein Labeling for Drug Discovery$374,969
R44 · FY2004 · GM
Mass Spectrometric Detection of Drug-Resistant HIV$299,927
R43 · FY2004 · AI
Molecular Test for Inherited Mutations in Breast Cancer$186,970
R43 · FY2004 · CA
Novel Technology for the Analysis of Gene Expression$914,409
R44 · FY2003 · CA
Novel Technology for the Analysis of Gene Expression$46,797
R44 · FY2003 · CA
Novel Technology for the Analysis of Gene Expression$604,343
R44 · FY2002 · CA
Novel In Vitro Expression Methods for Proteome Analysis$388,410
R44 · FY2002 · GM
Novel Technology for the Analysis of Gene Expression$598,064
R44 · FY2001 · CA
Novel In Vitro Expression Methods for Proteome Analysis$388,410
R44 · FY2001 · GM
Cell-Free Protein Labeling for Drug Discovery$98,440
R43 · FY2001 · GM
NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION$75,445
R43 · FY2001 · CA